|
RNF145 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03070000001537E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.03430000003768E-06 |
| Normal-vs-Stage2 |
6.700000E-03 |
| Normal-vs-Stage3 |
6.584800E-04 |
| Normal-vs-Stage4 |
1.035450E-03 |
| Stage1-vs-Stage2 |
6.916800E-01 |
| Stage1-vs-Stage3 |
5.047200E-01 |
| Stage1-vs-Stage4 |
8.669400E-01 |
| Stage2-vs-Stage3 |
4.593400E-01 |
| Stage2-vs-Stage4 |
8.151000E-01 |
| Stage3-vs-Stage4 |
5.119600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92731999999474E-05 |
| Normal-vs-AfricanAmerican |
1.776500E-04 |
| Normal-vs-Asian |
2.836400E-03 |
| Caucasian-vs-AfricanAmerican |
3.699600E-02 |
| Caucasian-vs-Asian |
4.945800E-01 |
| AfricanAmerican-vs-Asian |
2.883800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.24549999999968E-05 |
| Normal-vs-Female |
2.93989999999855E-06 |
| Male-vs-Female |
7.281200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.1483999999905E-05 |
| Normal-vs-Age(41-60Yrs) |
4.12149999999833E-05 |
| Normal-vs-Age(61-80Yrs) |
4.956800E-04 |
| Normal-vs-Age(81-100Yrs) |
3.907000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.693200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.252000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.340200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.077800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.950800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.382200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.087600E-01 |
| Classical-VS-Follicular |
9.813600E-01 |
| Classical-VS-Other |
4.499800E-02 |
| Classical-VS-Normal |
2.30719999994022E-07 |
| Tall-VS-Follicular |
2.776400E-01 |
| Tall-VS-Other |
1.431170E-01 |
| Tall-VS-Normal |
2.851700E-02 |
| Follicular-VS-Other |
1.682450E-01 |
| Follicular-VS-Normal |
1.042100E-03 |
| Other-VS-Normal |
6.654600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.65380000000304E-05 |
| Normal-vs-N1 |
4.862200E-02 |
| N0-vs-N1 |
1.601570E-01 |
|
|
